Analysis of the U.S. Multiparameter Patient Monitoring Equipment Market

The future of the multiparameter patient monitoring market will be monitors that help healthcare professionals manage clinical information across patients and units by capturing and interpreting key clinical measurements that will help improve patient outcomes while increasing efficiency. Growth in the hospital segment will continue to reflect low, single-digit growth rates with the strongest potential in critical care, transport and the emergency room environments. Alternate care will provide the strongest growth potential throughout the forecast period, reflecting mid-single digit growth.

U.S. Multiparameter Patient Monitoring Equipment Market

Published: March 2012
No. of Pages: 100
Price: US$6500   
 
United States Multiparameter Patient Monitoring Equipment Market
This market has historically suffered from the difficulties of market maturity and saturation. However, in recent years, certain trends have established a small degree of growth in this well-established market.
Multiparameter patient monitors are defined as monitoring systems that measure and display waveforms and numerical data for patient parameters that are used in the diagnosis and treatment of patients in various healthcare settings. These monitoring systems display multiple input signals from various kinds of vital sign-sensing devices, such as heart rate, respiratory rate, temperature, invasive and non-invasive blood pressure, end-tidal CO2, electrocardiograms (ECG), and arterial oxygen saturation. The monitor’s purpose is to convert these electrical signals into a readable form that is simultaneously shown on the monitor’s built-in display.

The region covered in this market is the United States and the segments covered are the hospital and alternate care settings.

 Major points covered in Table of Contents of this report include:

Executive Summary 4

Market Overview 9

Total Multiparameter Patient Monitoring Equipment Market -
External Challenges: Drivers and Restraints 17
Forecasts and Trends 23
Market Share and Competitive Analysis 33

Hospital Segment Breakdown 37

Alternate Care Segment Breakdown 70

The Last Word (Conclusions and Implications) 93

Appendix 98

Explore Reports related to Healthcare @ http://www.reportsnreports.com/market-research/healthcare/

Pulmonary Drug Delivery Systems: Technologies and Global Markets

• The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market is further projected to reach nearly $44 billion by 2016 at a compound annual growth rate (CAGR) of 14.3%.
• The market for metered dose inhalers (MDIs) was $12.5 billion in 2010 and will reach $14.4 billion by the end of 2011. BCC forecasts this market will grow to $29.8 billion by 2016 at a CAGR of 15.7%.
• The market for dry powder inhalers (DPIs) was $6.6 billion in 2010. This market is expected to increase to $7.5 billion in 2011 and reach $13.4 billion by 2016 at a CAGR of 12.3%.

Pulmonary Drug Delivery Technologies Market

Published: January 2012

No. of Pages: 207

Price: Single User License – US$4850              Corporate User License – US$8500

                                          

STUDY GOALS AND OBJECTIVES
This BCC market research report, Pulmonary Drug Delivery Systems: Technologies and Global Markets, provides a detailed overview and thorough analysis of the present and future global market for pulmonary drug delivery technologies.  This report analyzes in detail the pulmonary drug delivery technologies that are available and currently used and their markets.  This report includes products in this market and detailed analyses of the markets and competitive environments.  It also analyzes current and future market prospects.  The report provides a comprehensive review of emerging pulmonary drug delivery technologies, particularly with regard to inhaled drug delivery systems.  The analysis reviews technological developments, product innovations, and recent strategic industry activities of major players across different product categories.  It reviews their strengths and weaknesses, opportunities, and the threats facing various devices and drugs in this market space.  The report also reviews developments already on the market, major issues involved in the research and development (R&D) of more effective devices for drug delivery to the lungs, and new products in development.

REASONS FOR DOING THE STUDY
Pulmonary drug delivery has emerged as a more relevant alternative for delivering drugs.   Respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease are therapeutic areas of the pulmonary sector.  However, recent technological advancements have applied the application of pulmonary devices to the treatment of nonrespiratory conditions such diabetes and migraines.  Advancements in formulating technology are expected to push sales of dry powder inhalers, replacing metered-dose inhalers to a large extent.   Pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to the infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.   There is a need to understand the trends in this market, currently available devices and their problems, and the latest developments for drug delivery to the lungs.

SCOPE AND FORMAT
The report reviews global markets for drug delivery technologies and new developments, and forecasts trends for use of current devices for drug delivery and for safety and toxicology through 2016.   The report presents important devices, technologies, and the latest developments, market share by device and disease type, current products on the market, market share by company or product, and statistical information for types of respiratory diseases prevalent worldwide, with special emphasis on the U.S. market.   The report also includes current issues and trends affecting the industry including costs, and factors influencing demand will be discussed.  The report covers products in development, new technologies, trends, alliances, patents, and mergers.  The report offers market data with respect to segments and geography.  It also provides market trends with respect to drivers, restraints, and opportunities.

Explore Tables of Contents available in the report @ http://www.reportsnreports.com/reports/140371-pulmonary-drug-delivery-systems-technologies-and-global-markets.html.

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

Published: October2011
No. of Pages: 167
Price: $ 3500


China’s rapid economic development and numerous steps of reform undertaken by the Chinese central government since 1997 had clear and observable effects upon China’s total healthcare services market and product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, including increased funding, to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers. Analyst Emil Salazar focuses on these questions.

The report China Healthcare Reform Impact contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:
• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets provides data for business planning. The report also takes a look at the status and forecast of the three key healthcare markets in China:
• The Chinese Market for IVD products
• Regional Breakout of Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• The Chinese Market for Medical Device Products
• Regional Breakout of Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• The Chinese Market for Pharmaceutical Products
• Regional Breakout of Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)
This essential resource for anyone marketing a healthcare product to China was constructed using a combination of primary and secondary sources. Corporate reports, trade publications government information and medical journals, previous market research studies conducted by Kalorama and other sources were used. In some cases, interviews were used to determine forecasts and key trends.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

Wireless Opportunities in Healthcare 2011 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)

Published: October 2011
No. of Pages: 210
Price: $ 3995


In previous editions of Kalroama Information's wireless technologies market report, we described wireless IT systems and devices being used in some model healthcare environments. The use of these technologies has moved well beyond these settings and should be of interest to marketers of many products, even those outside of healthcare IT. While not every healthcare system has gone wireless, 2011 has seen no letdown in the implementation of these technologies in healthcare. Almost all healthcare organizations have had to adjust to the use of these technologies in some form.

Kalorama’s Wireless in Healthcare 2011 is your guide to the growing market for wireless healthcare applications in the United States. This report contains explanations that cut through the confusion surrounding technologies and provide readers with a total picture of wireless in healthcare.

Current and Future US Markets for Bluetooth, Zigbee, RFID, UWB, WMAN and WLAN
Since the previous edition, some technologies have performed better than others and 2010 results have led to reforecasting of some technologies. The competitive arena has not dramatically changed since last year, with a few key players dominating and opportunity for smaller companies, but developments have been interesting.

Browse All: Healthcare Market

The report provides:
• Discussion of Trends in the Wireless Technology in Healthcare Marketplace, Products and Customer Case Studies of Wireless Applications.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Healthcare Application.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Technology Type.
• Scores of Tables and Figures provide accessible information about the wireless in healthcare marketplace.
• Detailed Profiles of 9 Key Companies in this market, major products and key executives.
• Explanation of the Major Technologies, ( Zigbee, Bluetooth, RFID, UWB, WMAN and WLAN )that are being used in healthcare.

Because of the focus on healthcare IT in the United States, the report focuses on this region. Some discussion of non-US opportunities and company efforts is included. The report provides today’s market figures and realistic projections for future revenues based on consideration of data and extensive interviews with industry experts. Looking at several detailed case studies, the report shows how wireless is already being used by major healthcare companies across a wide variety of applications, including:
• Hospitals
• Homecare and Telemedicine
• Pharmaceutical Research (Clinical Drug Trials)
• Inventory Control
• Pharmaceutical Sales Force Management
• Inventory Control
• Physician Offices
• Nursing Homes
• Medical and Diagnostic Laboratories
• Patient Monitoring

Case Studies
The report looks at several case studies where wireless technologies were implemented at various healthcare concerns and assesses the benefits derived from implementaton. Some case studies include:
• Sentara Healthcare's Electronic Medical Records and Wireless Technologies Information Technology System
• Rural Wireless Healthcare: 3G Mobile Medicine Partners in 3G Mobile Medicine Project
• George Washington University Hospital - WLAN Implementation
• Meridian At Home Pilot Program, Benefits of Implementation
• Memorial Medical Center - WLAN Implementation Requirement for Implementation of Wireless Technologies
• Cardinal Health and RFID Implementation
• Achieve Healthcare Technologies - e-Prescription
• Bayer Healthcare - e-Drug Trials and Requirement for e-Drug Trials

The report details the companies in this field - and why there is still an opportunity for new competitors. It discusses the currently implemented technologies and the technologies to watch that in four years, will gain impressive market share. Finally, it describes the trends that will push market expansion and reduction of cost of these devices. The healthcare applications and marketplace for the following technologies are discussed in detail:
• Bluetooth,
• Zigbee,
• RFID
• UWB
• Wireless Local Area Networks (WLAN)
• Wireless Metropolitan Area Networks (WMAN)
• Wireless Wide Area Networks (WWAN)

As a global report, Wireless Opportunities in Healthcare will look at opportunities available in the European Union and at Asian markets, while focusing on the US market
Kalorama’s unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with wireless technology company representatives included marketing directors, division managers, and product development representatives.

In addition to superior coverage of the overall wireless healthcare market, in-depth company profiles are included for the following wireless technology companies:
• Allscripts Healthcare Solutions, inc.
• Cerner Corporation
• Cisco Systems, Inc.
• Extreme Networks, Inc.
• GE Healthcare
• Hewlett Packard Corporation
• McKesson Corporation
• Medtronic, Inc.
• Motorola Solutions, Inc.
• Philips Healthcare
• Siemens Healthcare

Medical Imaging Markets: Image-Guided Surgery

Published: August 2011
No. of Pages:130
Price: $ 3500







Imaging technology used to diagnose illness and injury is increasingly being used to assist surgeons complete procedures. Interventional radiology or image-guided surgery involves the use of a real-time correlation of the operative field to preoperative imaging data that reflect the precise location of a surgical instrument to the surrounding anatomical structures. Preoperative scans from different imaging modalities provide additional diagnostic information. These scans can help a surgeon assess the adequacy of a repair.

As the number of minimally invasive surgical procedures has increased, though, other imaging modalities have been applied to address the limitations of x-rays and fluoroscopy. Computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and molecular imaging have provided the information required to plan and perform complex interventions inside the body without the need for direct open visual inspection by a surgeon.

Kalorama Information's Medical Imaging Markets: Image-Guided Surgery provides insight into the use of imaging to assist surgical performance, with procedure and market data for the US, Europe, Asia and ROW for the following modalities:
• X-Ray Fluoroscopy
• CT
• MRI
• Ultrasound
• PET
The report also provides revenue and procedure numbers based on procedures completed.

The following companies active in this field are profiled:
• B K Medical
• Brainlab AG
• Compass International Innovations
• Curexo Technology Corp.
• Elekta AB
• GE Healthcare
• Image Guided Therapy
• Imris
• Integra Lifesciences Holdings
• Medtronic
• NDS Surgical Imaging
• Philips Healthcare
• Siemens Healthcare
• SiteSelect Inc.
• Smith & Nephew plc
• St. Jude Medical Inc.
• Stryker Corp.
• SurgiVision Inc.
• Toshiba America Medical Systems Inc.
• TrueVision Systems
• Ultrasonix Medical Corp.
• Xograph Healthcare Ltd.
• Varian Medical Systems Inc.
• Vital Images Inc.
• Zimmer

The report also examines trends in the industry, including:
• Partnering for Image-Guided Surgery
• Improved Vascular Guidance
• Image-Guided Biopsies on the Rise
• Radiologists’ Role Increases
• Reducing Radiation Exposure
• Reducing Shoulder Pain
• Improving Spinal Surgery Outcomes
• Cone-Beam Computed Tomography
• Greater Use of Needle Biopsies
• MIS Lateral Approach Platform
• Image and Robotic Guidance
• MR-Guided Ultrasound

Out of Pocket Healthcare Spending 2011

Published: April 2011
No. of Pages: 85
Price: $ 1995







The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates. According to the U.S. Department of Labor, the average household's spending on health care after inflation has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket costs rising by more than 2% each year as a result of increased spending on prescription drugs.

While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Unique financial services have been created to facilitate non-insurance-paid health care services, and more are expected to be created in the near term.

This report, Out of Pocket Healthcare Spending 2011 focuses on those costs of health care which are not paid for by government or private insurance. Once a small percentage of costs of the health care system, the percentage borne by the consumer is increasing steadily. Included in the report is:
• Estimates of the Current 'Out of Pocket' Healthcare Spending Market and Forecasts to 2015.
• Breakdown of Spending by Type (Elective, Hospital, Emergency Room, Dental, Vision Outpatient, Prescription Drugs, Office Based Visit, Other)
• Health Care Reform and Its Impact on Out of Pocket Spending
• Statistics For the Types of Consumers Most Likely to Pay Out of Pocket
• Drivers of the Out of Pocket Trend and Potential Limiters
• Overview of the U.S. Healthcare System, Insured and Uninsured Population.
• The Types of Services and Products Purchased with Out of Pocket dollars
• Overview of the growing Healthcare Finance market and a look at key competitors.
The economic recession of December 2007 to October 2009 represented a major downturn that led to broad-based cost-cutting, rising unemployment and reduced disposable income. The impact of the pullback - which some experts compared to the Great Depression of 1929 to 1934 - cannot be overstated. Kalorama Information looks at what change has resulted in out of pocket expenditure for healthcare as a result of the recession and weak recovery.

As part of Kalorama Information's trusted process, secondary research from government, medical and industry sources was utilized along with interviews with industry experts in the healthcare finance industry.

In Weak Recovery, Consumers Bearing More of Healthcare Costs

Healthcare costs paid out-of-pocket by consumers have increased steadily in recent years, but according to Kalorama Information, the recession and weak recovery are additional drivers for the trend. In fact, the independent healthcare market research firm has found in its new report, Out of Pocket Healthcare Spending 2011, that out-of-pocket healthcare spending was $303 billion in 2010 and the rate of growth will accelerate at 8% annually in the coming years.

According to the U.S. Department of Labor, the average household's inflation-adjusted spending on healthcare has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket healthcare costs rising by more than 2% each year as a result of increased spending on prescription drugs.

"The recent recession brought with it a high unemployment rate, exacerbated by increased outsourcing of jobs to lower cost countries, broad-based cost-cutting and reduced disposable income," said Bruce Carlson, publisher of Kalorama Information. "Meanwhile, affordable healthcare has become less available but more necessary."

The costs of healthcare products and services continue to rise briskly; in some cases, they have become astronomical. For example, in 2010, average annual healthcare premiums for a family of four ($13,770) approached annual earnings at the federal minimum wage ($14,500). As a result, Kalorama notes that managed care organizations are increasingly shifting the burden of healthcare costs to consumers by way of increased co-pays and premiums.

About 70% of consumers' out-of-pocket healthcare spending goes to premiums. And this is increasing as HMOs and employers engage in cost shifting. Co-pays make up a little over 3% of spending, which Kalorama also expects to increase due to cost shifting. Another 27% of out-of-pocket spending goes to direct payments.

The Health Care Reform of 2010 has significantly changed the landscape of the U.S. healthcare industry by extending healthcare coverage to approximately 32 million previously uninsured people. Although this could potentially decrease some demand for out-of-pocket spending from the previously uninsured, it may in fact, raise awareness of the value of basic care and bring more persons into the medical system, thus potentially increasing spending as newly insured consumers take a renewed interest in their health and wellness.

Minimally Invasive Surgical Devices, World Market

Published: May 2011
No. of Pages:150
Price: $ 3500







Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the Minimally Invasive Surgical devices market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers. Additionally key company profiles are included.


Browse All: Healthcare Market Research

The report provides total market sizes in six general surgery areas reflecting revenues earned by all manufacturers in all MIS methods in those areas. Revenues for each therapeutic area. were gathered through both primary and secondary research methods. General surgery areas include:
• Orthopedic MIS Device Market (included in total market size number in this report are arthoscopes, autoclavable laoparoscope, holmium lasers, other devices)
• Neurosurgery MIS Device Market (included in total market size number in this report are neuroendoscopes, bronchoscope, esophoscope, others)
• ENT/Respiratory MIS Device Market (included in total market size number in this report are laryngoscopes, ventriculoscopes, contact lasers, others)
• Cardiovascular MIS Device Market (included in total market size figure are laparoscopes, ablation systems, endoscopes, others)
• Gastrointestinal System MIS Device Market (included in total market size figure are endoscopes, sigmoidoscopes, videoscopes, others)
• Urological and Gynecological MIS Device Market (included in total market size figure are hysteroscopes, cystoscopes, others)
The purpose of this report is to provide understanding of the total current market for all MIS methods for each therapeutic area. In the scope of this report they are considered as competitive methods and are not broken down to specific device segments (for instance 'Gastroinestinal System Devices' will contain a number for all competiting MIS methods in GI, but will not have a specific sigmoidoscope or GI endoscope number.)

Five year forecasts are also provided. As this is a global survey, Revenues are provided for the following regions:
• US
• Europe
• Rest of World

Procedure volumes are available for the following surgeries for which minimally invasive equipment is utilized:
• Hip Replacement, Pinning, etc.
• Knee Repair/Fixation, Procedures
• Spinal Fusion/Spinal Hardware Removal
• Shoulder Repair/Fixation
• Lumbar Laminectomy/ Thoracic-lumbar
• Laminectomy/Diskectomy and Lumbar Decompression and Fusion
• Craniotomy (all types)
• Ventricular-Peritoneal Shunt Insertion/ Removal/Revision
• Detether Cord (adult and pediatric)
• Ethmoidectomy
• Tonsillectomy
• Thyroidectomy
• Coronary Revascularization
• Aortic Valve Replacement or Repair
• Cardiac Catheterization
• Insertion of Coronary Artery Stent(s)
• Appendectomy
• Endoscopy with or without biopsy
• Cholecystectomy
• Inguinal Herniorrhaphy
• Hysterectomy (all types)
• Prostatectomy

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 45 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives:
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Compound annual growth rates (CAGRs) are provided for each region and/or segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for was largely based on demographic trends, new developments, and global expansion.